Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
US9393245B2 · kind B2 · utility
5Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2015 |
| Grant date | Jul 19, 2016 |
| Priority date | — |
| Expiry date | Sep 10, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.